Cargando…
Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report
A first case of clinical tenofovir (TDF) HBV resistance in an HIV/HBV coinfected patient who developed an acute flare of hepatitis B is reported. The clinical course was accompanied by signs of acute liver failure after being on successful HBV treatment with tenofovir and persistently undetectable H...
Autores principales: | Schewe, Knud, Noah, Christian, Sirma, Hüseyin, Schmiedel, Stefan, van Lunzen, Jan, Rockstroh, Jürgen Kurt, Schildgen, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185722/ https://www.ncbi.nlm.nih.gov/pubmed/21994693 http://dx.doi.org/10.3390/v2081564 |
Ejemplares similares
-
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011) -
Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015) -
Evaluation of miR-222 Expression in HBV Infected Patients in Comparison with HDV and HBV Co-infected Patients
por: Sokhanvar, Zahra, et al.
Publicado: (2021) -
Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates
por: Ali, Maisa M, et al.
Publicado: (2010) -
A PCR assay to quantify patterns of HBV transcription
por: D’Arienzo, Valentina, et al.
Publicado: (2019)